# Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial

> **NCT01585779** · — · COMPLETED · sponsor: **Medtronic Cardiovascular** · enrollment: 64 (actual)

## Conditions studied

- Tricuspid Valve Regurgitation
- Tricuspid Valve Insufficiency

## Interventions

- **DEVICE:** Contour 3D® implant for tricuspid valve repair
- **DEVICE:** Tri-Ad® implant for tricuspid valve repair

## Key facts

- **NCT ID:** NCT01585779
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2017-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01585779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01585779, "Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01585779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*